For over two decades  the pharmaceutical industry has been  by far  the most profitable in the United States  steadily rising to its unprecedented $200-billion-a-year status in recent years Yet in the wake of blockbuster failures like Neurontin  Paxil  and Vioxx  the pharmaceutical industry has proven that its rise has induced less of an enhancement in product quality and safety than a worrisome trend toward the exact opposite